September / October 2007
The Ticker
Whose Stock is Rising-And Whose Isn't
Whose stock is rising-and whose isn't. Al Franken, Crown Princess Masako, Medical Marijuana - buy, hold, or sell?
-
Al Franken
The Minnesota Senate candidate raised almost $2million in the most recent reporting period, more than any other candidate for that seat from either party.
-
Doris Kearns Goodwin
After the success of Team of Rivals, about the Lincoln presidency, helped Goodwin put a plagiarism scandal behind her, the historial was the go-to pundit when Lady Bird Johnson died.
-
Pandora
Headed by CEO Joe Kennedy (no, not the former congressman), the music website says that about seven million users are selecting songs on www.pandora.com.
-
Dr. Christoph Westphal
The chief executive of Sirtis Pharmaceuticals has partnered with Harvard pathologist David Sinclair to develop a pill that will slow aging. But will we all be dead before any drug gets approved?
-
Susan Decker
The new Yahoo! president faces an uphill battle for ad dollars against archrival Google, especially with rumors that her ad execs are looking for greener pastures.
-
Medical Marijuana
A new study headed by Jerome Groopman finds that THC, marijuana's main psychoactive ingredient, can facilitate the spread of Kaposi's Sarcoma, a cancer that is lethal for people with lowered immune systems.
-
Crown Princess Masako
The 43-year-old has been diagnosed by court physicians with an " adjustment disorder, " and is chronically unable to travel abroad with her husband, Japan's Crown Prince Naruhito.
-
Mohamed A. El-Erian
Harvard's investment chief put $700 million of Harvard's endowment into Soweed Capital Management, a hedge fund founded by the school's former foreign-stock holdings manager, Jeffrey Larson. Oops. In July, Soweed lost more than 50% of it's value due to bad bond investments. Harvard lost about $350 million.
Magazine
Most Popular:
More Like This
The Rankings:
People Most Mentioned:
Subscribe to 02138
02138 is not automatically mailed to all Harvard alumni.
Enter your email and name below to reserve your FREE Trial Issue!
Your privacy is ensured. We never sell, disclose, or trade contact information.
02138 is an independent magazine and is not affiliated with Harvard University. Please note that 02138 is available to the general public by subscription only, but is not automatically mailed to all Harvard alumni.